A transgenic mouse model of the slow-channel syndrome

Muscle and Nerve

Volumn 19, Issue 1, 1996, Pages 79-87

  Gomez, Christopher M ^a,f   Bhattacharyya, Bula B ^a   Charnet, Pierre ^b   Day, John W ^a   Labarca, Cesar ^c   Wollmann, Robert L ^d   Lambert, Edward H ^e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b CNRS   (France)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e MAYO CLINIC   (United States)

^f Box 295 UMHC ^*  (United States)

Author keywords

acetylcholine receptor; mutation; myasthenic; slow channel; transgenic

Indexed keywords

CHOLINERGIC RECEPTOR; CURARE; ION CHANNEL;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FEMALE; GENE MUTATION; HISTOPATHOLOGY; MINIATURE ENDPLATE POTENTIAL; MOUSE; MUSCLE ACTION POTENTIAL; NEUROMUSCULAR DISEASE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; CURARE; DISEASE MODELS, ANIMAL; ELECTROMYOGRAPHY; FEMALE; GENE EXPRESSION; HUMANS; ION CHANNELS; MICE; MICE, TRANSGENIC; MOTOR ENDPLATE; MUTATION; NEUROMUSCULAR DISEASES; PATCH-CLAMP TECHNIQUES; RECEPTORS, CHOLINERGIC; SYNAPTIC TRANSMISSION; XENOPUS LAEVIS;

EID: 0030031636     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199601)19:1<79::AID-MUS11>3.0.CO;2-Z     Document Type: Article

References (35)

1. Anderson CR, Stevens CF: Voltage clamp analysis of acetylcholine produced end-plate current fluctuations at frog neuromuscular junction. J Physiol 1973;235:655-691.
2. Berman PW, Patrick J: Experimental myasthenia gravis. A murine system. J Exp Med 1980;151:204-223.
3. Bhattacharysa B, Day JW, Gomez CM: Transgenic mice with slow acetylcholine receptor (ACHR) ion channels: reduced miniature endplate current (MEPC) amplitudes may be due to AChR desensitization. Soc Neurosci Abstracts 1994; 20:713.
4. Brenner HR, Witzemann V, Sakmann B: Imprinting of acetylcholine receptor messenger RNA accumulation in mammalian neuromuscular synapses. Nature 1990;344: 544-547.
5. Buskin JN, Jaynes JB, Chamberlain JS, Hauschka SD: The mouse muscle creatine kinase cDNA and deduced amino acid sequences: comparison to evolutionarily related enzymes. J Mol Evol 1985;22:334-341.
6. Charnet P, Labarca C, Lester HA: Structure of the gammaless nicotinic acetylcholine receptor: learning from omission. Mol Pharmacol 1992;41:708-717.
7. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
8. Dionne VE, Stevens CF: Voltage dependence of agonist effectiveness at the frog neuromuscular junction: resolution of a paradox. J Physiol 1975;251:245-270.
9. Ellman GL, Courtney KD, Andres V, Featherstone RM: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
10. Engel AG: Myasthenic syndromes, in Engel AG, Franzini-Armstrong C (eds): Myology, 2nd ed. New York, McGraw-Hill, 1994, pp 1798-1835.
11. Engel AG, Lambert EH, Gomez MR: A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release. Ann Neurol 1977;1:315-330.
12. Engel AG, Lambert EH, Mulder DM, Torres CF, Sahashi K, Bertorini TE, Whitaker JN: A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Ann Neurol 1982;11:553-569.
13. Feinberg AP, Vogelstein B: "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity." Addendum. Anal Biochem 1984;137:266-267.
14. Gammack J, Maselli R, Labarca C, Gomez C: A beta subunit mutation in a putative gate of the acetylcholine receptor (AChR) channel causes a congenital myasthenic syndrome (CMS). Soc Neurosci Abstracts 1995;21:1490.
15. Gardner PD: Nucleotide sequence of the epsilon-subunit of the mouse muscle nicotinic acetylcholine receptor. Nucl Acids Res 1990:18
16. Gomez CM, Wollmann RL, Richman DP: Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor. Acta Neuropathol 1984;63: 131-143.
17. Gomez CM, Gammack JT: A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome. Neurology 1995;45: 982-985.
18. Gomez CM, Richman DP: Antibody to alpha-bungarotoxin binding site of acetylcholine receptor: a new form of experimental myasthenia. Proc Natl Acad Sci USA 1983;80: 4089-4093.
19. Gomez CM, Richman DP: Chronic experimental autoimmune myasthenia gravis induced by monoclonal antibody to acetylcholine receptor: biochemical and electrophysiologic criteria. J Immunol 1987;139:73-76.
20. Gorman CM, Moffat LF, Howard BH: Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 1982;2:1044-1051.
21. Hogan R, Constantini F, Lacey E: Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1986.
22. Horowitz SH, Genkins G, Kornfield P, Papatestas AE: Electrophysiologic diagnosis of mvasthenia gravis and the regional curare test. Neurology 1979;26:410-417.
23. Johnson JE, Wold BJ, Hauschka SD: Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice. Mol Cell Biol 1989;9: 3393-3399.
24. Keesey JC: AAEE Minimonograph 33: Electrodiagnostic approach to defects of neuromuscular transmission [see comments]. Muscle Nerve 1989;12:613-626.
25. Kuffler SW: Responses during refractory period of myoneural junction in isolated nerve-muscle fiber preparation. J Neurophysiol 1942;5:199-209.
26. Lambert EH, Lindstrom JM, Lennon VA: End-plate potentials in experimental autoimmune myasthenia gravis in rats. Ann AY Acad Sci 1976;274:300-318.
27. Lapolla RJ, Mayne KM, Davidson N: Mouse muscle nicotinic acetylcholine receptor 8 subunit: cDNA sequence and gene expression. Proc Natl Acad Sci USA 1984;81: 7970-7974.
28. Ohno K, Brengman J, Hutchinson D, Griggs R, Engel A: A congenital myasthenic syndrome with two distinct mutations in the epsilon subunit of the acetylcholine receptor. Muscle Nerve 1994;Suppl 1:S226.
29. Ohno K, Hutchinson D, Milone M, Brengman J, Bouzat C, Sine S, Engel A: Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the ε subunit. Proc Natl Acad Sci USA 1995;92:758-762.
30. Ohno K, Hutchinson D, Milone M, Nakano S, Sieb J, Brengman J, Engel A: Molecular genetic basis of a slow channel myasthenic syndrome. Surprise Box, 8th International Congress on Neuromuscular Diseases. Muscle Nerve 1994;18:463.
31. Oosterhuis HJ, J. N-D, Wokke JH, Molenaar PC, Weerden TV, Oen BS, Jennekens FG, Veldman H, Vincent A, Wray DW, Prior C, Murray NMF: The slow channel syndrome. Two new cases. Brain 1987;110:1061-1079.
32. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-491.
33. Sambrook J, Fritsch FE, Maniatis T: Molecular Cloning, A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Press, 1989.
34. Treinin M, Chalfie M: A mutated acetylcholine receptor subunit causes neuronal degeneration in C. elegans. Neuron 1995;14:1-20.
35. Yu L, LaPolla R, Davidson N: Mouse muscle nicotinic acetylcholine receptor γ subunit: cDNA sequence and gene expression. Nucl Acids Res 1986;14:3539-3555.